Work

Prevention of Hepatitis C Virus in Injecting Drug Users: A Narrow Window of Opportunity

Year: 2011

Type: article

Abstract: and hepatitis C virus (HCV) infections remain major public health problems among injecting drug users (IDUs). In 2007, it was estimated that there were 15.9 million IDUs worldwide, with 3 million living with HIV [1]. While similar data are not available for HCV, given an HCV prevalence of 65 % [2], it is estimated that 10 million active IDUs have been exposed to HCV and 8 mil-lion have chronic infection. The global burden of HCV is even greater in former IDUs. Implementation of harm reduction strategies since the early 1990s among

Source: The Journal of Infectious Diseases

DOI: 10.1093/infdis/jiq111

Authors: Jason Grebely, Gregory J. Dore

Institution: UNSW Sydney

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Australian Government, University of New South Wales, Medical Research Council, National Health and Medical Research Council